Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to -$0.49.

  • Lisata Therapeutics' EPS (Basic) rose 1694.92% to -$0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.13, marking a year-over-year increase of 1513.94%. This contributed to the annual value of -$2.4 for FY2024, which is 699.82% up from last year.
  • As of Q3 2025, Lisata Therapeutics' EPS (Basic) stood at -$0.49, which was up 1694.92% from -$0.54 recorded in Q2 2025.
  • In the past 5 years, Lisata Therapeutics' EPS (Basic) registered a high of -$0.49 during Q3 2025, and its lowest value of -$0.77 during Q1 2023.
  • Its 3-year average for EPS (Basic) is -$0.6, with a median of -$0.59 in 2024.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 2200.0% in 2024, then soared by 1694.92% in 2025.
  • Over the past 3 years, Lisata Therapeutics' EPS (Basic) (Quarter) stood at -$0.66 in 2023, then grew by 16.14% to -$0.55 in 2024, then grew by 11.47% to -$0.49 in 2025.
  • Its EPS (Basic) stands at -$0.49 for Q3 2025, versus -$0.54 for Q2 2025 and -$0.55 for Q1 2025.